ArticleApplied and environmental microbiology2007
Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters.
Article in Applied and environmental microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 173 citations in OpenAlex.
- Antimicrobial Resistance and Associated Genetic Determinants ofAntibiotics (Basel, Switzerland) · 2026Article
- L-cysteine inhibited the growth ofApplied and environmental microbiology · 2026Article
- Spatiotemporal distribution and diversity of pathogenicApplied and environmental microbiology · 2026Article
- Multifunctional Edged-Satellite AuAg Nanoparticles-Based Integration Platform for Screening, Validation, and Elimination of Vibrio Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Isolation, Genomic Taxonomy, and Genome Characterization of Streptomyces fradiae SS162, Which has Antibacterial Activity Against Vibrio parahaemolyticus.Current microbiology · 2025Article
- Antimicrobial resistance ofApplied and environmental microbiology · 2025Article
- Epidemiological characteristics, virulence genes, and antimicrobial resistance analysis ofFrontiers in microbiology · 2025Article
- Article
- Antibiotic resistance trends amongApplied and environmental microbiology · 2024Article
- Evaluation of In Vitro Synergistic Effects of Tetracycline with Alkaloid-Related Compounds against Diarrhoeic Bacteria.International journal of molecular sciences · 2024Article
- Microbiological and Toxicological Investigations on Bivalve Molluscs Farmed in Sicily.Foods (Basel, Switzerland) · 2024Article
- Spotlight on the epidemiology and antimicrobial susceptibility profiles ofFuture microbiology · 2024Review
- Molecular characterization of Vibrio species isolated from dairy and water samples.Scientific reports · 2023Article
- Antimicrobial Resistance Risk Assessment ofMicroorganisms · 2023Article
- Quantitative Risk Evaluation of Antimicrobial-ResistantPathogens (Basel, Switzerland) · 2023Article
- Article
- Antibiotic Resistance and Epidemiology ofInfection and drug resistance · 2023Article
- Prevalence and antimicrobial resistance profiles ofFrontiers in microbiology · 2023Article
- Occurrence and Molecular Characterization of Potentially PathogenicMicroorganisms · 2022Article
- Recovery of Pasteurization-ResistantFoods (Basel, Switzerland) · 2022Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antimicrobial susceptibilities of 168 Vibrio parahaemolyticus and 151 Vibrio vulnificus isolates recovered from 82 Louisiana Gulf and retail oysters in 2005 and 2006 were determined. Overall, the two vibrios remained susceptible to the majority of antimicrobials tested; reduced susceptibility was detected only in V. parahaemolyticus for ampicillin (81%; MIC > or = 16 microg/ml). Additionally, V. parahaemolyticus displayed significantly higher MICs for cefotaxime, ciprofloxacin, and tetracycline than V. vulnificus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.